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ABSTRACT  The low density lipoprotein  (LDL) receptor is a member of a class of receptors that bind 
macromolecules  at the cell  surface and facilitate  their cellular  uptake  by receptor-mediated  endo- 
cytosis. The  orientation  of the  LDL receptor  in the  plasma  membrane  is unknown.  In  the current 
studies the sequence of amino acids at the  NH2-terminus of the bovine adrenal LDL receptor was 
determined,  and a synthetic  peptide corresponding to amino acids 1-16 was prepared. Antibodies 
against this  peptide  were  raised  in  rabbits  and  were  shown  by  immunoblotting  analysis  to  react 
specifically  with the  bovine  LDL receptor. The anti-receptor  peptide antibodies also bound to the 
LDL receptor on the outer surface of the plasma membrane of intact human fibroblasts, as visualized 
by indirect immunofluorescence.  Specificity  of this binding reaction was confirmed  by the observa- 
tion that the anti-receptor peptide antibodies did not bind to mutant fibroblasts from a patient with 
homozygous familial  hypercholesterolemia that lack LDL receptors. These data demonstrate that the 
LDL  receptor  is oriented  in  the  plasma  membrane  with  its  NH2-terminus  facing  the  extracellular 
surface. 
Certain proteins on the surface of animal cells serve as recep- 
tors that facilitate the uptake of extracellular macromolecules 
by receptor-mediated endocytosis. Among these proteins is 
the receptor for plasma low density lipoprotein (LDL), ~ the 
major cholesterol  transport  protein  in  human  plasma  (l). 
After LDL binds to its receptor, the ligand/receptor complex 
enters the cells in coated pits and coated vesicles. The LDL is 
subsequently delivered to lysosomes, where it is digested; this 
liberates its cholesterol for metabolic use by the cell. Receptors 
for a variety of other ligands, including glycoproteins, insulin, 
transferrin,  lysosomal enzymes, and certain  lipid-enveloped 
viruses, also enter cells through coated pits (2, 3). It has been 
postulated that  receptors may enter coated pits by binding 
directly or indirectly to clathrin,  the structural  protein that 
coats the cytoplasmic surface of these pits (2, 4). This hypoth- 
esis  implies that the cytoplasmic domain of these  receptors 
may share some common determinant that binds to clathrin 
or  some clathrin-associated  protein.  The  nature  of such  a 
putative recognition marker is not known. 
' Abbreviation used in this paper:  LDL, low density lipoprotein. 
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The  structures  of several  of the  receptors that  mediate 
endocytosis through coated pits are beginning to be elucidated 
(5). The complete amino acid sequences of the hepatic recep- 
tor for glycoproteins in the chicken (the agalactoglycoprotein 
receptor) (6) and of the related hepatic receptor in the rat (the 
asialoglycoprotein  receptor)  (7)  have  been  determined  by 
Drickamer and co-workers. As deduced  from the sequence 
data, the NH2-terminus of both of these receptors is appar- 
ently located on the cytoplasmic side of the membrane with 
the COOH-terminus located on the exterior side.  This ori- 
entation is opposite that of several previously studied plasma 
membrane proteins that do not concentrate in coated pits, 
such as glycophorin of red blood cells (8),  the G  protein of 
vesicular stomatitis virus (9),  and the histocompatibility an- 
tigens  of mammalian cells (10).  The questions  arise  as to 
whether all endocytosis-mediating receptors are oriented with 
their  NH2-terminus  on  the  inside  of the  membrane  and 
whether such an orientation might be necessary for receptor 
binding to coated pits. 
Recent studies have shown that antibodies made against 
short  synthetic  peptides  can  react  with  the  corresponding 
1635 amino acid sequence present in the native protein structure 
(11,  12). For example, antibodies prepared against short syn- 
thetic peptides corresponding to  segments of the  influenza 
virus hemagglutinin react with the intact hemagglutinin on 
the viral envelope (13). 
In the current studies, we have used this new immunologic 
technique to locate the NH2-terminus of the LDL receptor. 
Although  the  receptor is  only a  minor component of total 
cellular protein, it can be purified from bovine adrenal cortex 
in milligram amounts (14,  15). It is a single glycoprotein chain 
of apparent  Mr  160,000,  as determined  by SDS  PAGE.  It 
behaves  as  an  integral  membrane  protein  that  spans  the 
plasma membrane.  We  identified  the  first  16  amino  acid 
residues  from the  NH2-terminus of the  LDL receptor and 
prepared a synthetic peptide corresponding to this sequence. 
Antibodies to the peptide reacted with the extraceUular (ex- 
posed) portion of the LDL receptor in intact human  fibro- 
blasts, demonstrating that the NH2-terminus of the receptor 
is on the external surface of the plasma membrane. 
MATERIALS  AND  METHODS 
Materials:  We obtained female New Zealand White rabbits weighing 2 
kg from Hickory Hills Rabbitry,  Hint, TX; keyhole limpet hemocyanin  (cat. 
no.  374817) from Calbiochem-Behring  Corp.,  La Jolla, CA; goat anti-rabbit 
lgG (IgG fraction, Cat. No. 0212-0081) from Cappel Laboratories, Inc., Coch- 
ranville, PA; goat anti-rabbit  IgG (affinity-purified fraction) coupled to fluores- 
cein isothiocyanate (cat. no. 62-6111) from Zymed Laboratories, San Francisco, 
CA; and [3H]iodoacctic acid ( 100-300 mCi/mmol)  from New England Nuclear, 
Boston, MA. Disuccinirnidyl suberate was synthesized by Dr. J. R. Falck in 
our Department  of Molecular Genetics. A polyclonal antibody directed against 
the purified bovine adrenal  LDL receptor was raised in rabbits, and an IgG 
fraction was prepared (16). Other materials were obtained as previously reported 
(15-18). 
Purification  of  LDL  Receptor  from  Bovine  Adrenal  Cor- 
tex:  The LDL receptor was purified to homogeneity by chromatography  on 
DEAE-cellulose followed by chromatography  on an immunoaffinity  column 
containing a monoclonal antibody directed against the LDL receptor (15). 
Preparation of LDL Receptor for Sequencing:  Beforesequenc- 
ing, LDL  receptor  preparations  were  reduced  and  alkylated.  In  a  typical 
experiment, lyophilized LDL receptor (1.6-1.8 mg protein) was dissolved in  1 
ml of buffer containing  0.5 M Tris-chloride (pH 8.2), 7 M guanidine,  2 mM 
EDTA, and  30  mM 2-mercaptoethanol.  The tube  was flushed with N2 and 
incubated for 2 h at 37"C. [3H]Iodoacctic acid ( l mCi dissolved in above buffer 
without  EDTA and 2-mercaptoethanol)  was then added. After 30 min in the 
dark at room temperature,  solid unlabeled iodoacetic acid was added to a final 
concentration  of 40 mM. The incubation  was continued  for 15 min at room 
temperature in the dark. The solution was dialyzed at 4"C against three changes 
of 6 1 each of 0.25 M NH4OH and lyophilized. The reduced and 3H-carboxy- 
methylated LDL receptor preparations were subjected to amino acid sequence 
analysis as described below. For one of the sequencer runs, a CNBr digest of 
reduced and 3H-carboxymethylated LDL receptor was prepared by dissolving 
1.8 mg protein  in 2 ml of 70% formic acid and adding 25 mg of solid CNBr 
(19). After incubation  for 32 h at room temperature,  8 ml H20 was added, and 
the  solution  was lyophilized.  The peptides  were separated  by  reverse phase 
high-performance  liquid chromatography  using a  Brownlee RP  300 column 
(Brownlee Labs Inc., Santa Clara, CA). 
Sequencing:  Reduced  and ~H-carboxymethylated LDL receptor  was 
subjected to automated  amino acid sequence analysis using Beckman 890C or 
890D amino acid sequencers (Beckman Instruments, Inc., Palo Alto, CA). 0.25 
M  and  0.1  M  Quadrol  programs  were employed  in  conjunction  with  the 
nonprotein carrier Polybrene (20). The phenylthiohydantoin  amino acid deriv- 
atives were identified by high-performance liquid chromatography  using both 
a Waters RCM C 18 and an RCM CN column for each determination.  Cysteine 
residues were identified by radioactivity. Amino acids in the first 16 positions 
were assigned on the basis of 5 sequencer  runs.  Yields of the  NH2-terminal 
residue ranged between  100 and 700 pmoles per run. Repetitive yields, based 
on recovery of phenylthiohydantoin-13H]cysteine, averaged 92%. The NH2- 
terminal  sequence of the LDL receptor  was also determined  from a peptide 
that was fortuitously found among several peptides generated by CNBr digestion 
and isolated by reverse-phase high-performance liquid chromatography.  In the 
sequencer run on this latter peptide, recovery of the NH2-terminal residue was 
600 pmol and the repetitive yield was 89%. 
Synthesis of NH2-terminal  Peptide of LDL Receptor (Recep- 
tor Peptide):  The 16-residue peptide corresponding to the NH2-terminal 
sequence of the LDL receptor (Table I) was synthesized by Peninsula Labora- 
tories, Inc., Belmont, CA, with the use of solid-phase methods developed by 
Merrifield and co-workers (see reference 21). Its composition  was confirmed 
by amino acid analysis, and its sequence was confirmed  in our laboratory by 
amino acid sequence analysis. The  receptor  peptide was coupled  to keyhole 
limpet hemocyanin at room temperature as follows. A solution of hemocyanin 
in 50% glycerol (80 td containing  l0 mg protein)  was mixed with 420 ~l of 
buffer A (0.14 M NaCl, 1.6 mM KCI, 1. l mM KH2PO4, and 8 mM Na2HPO4 
at pH 7.4). A freshly prepared solution (20 zl) of  0. l M disuccinimidyl suberate 
in dimethylsulfoxide was added and the mixture was stirred for l0 min. Then, 
6.3 mg of solid receptor peptide was added and stirring was continued  for 90 
min.  Finally, 500 zl of buffer A was added and, after stirring for 30 rain, the 
material was divided into  160-zl aliquots and stored at -20"C. 
Immunizations:  To obtain  the  anti-receptor peptide  antibodies,  we 
injected rabbits subcutaneously on days 0,  14, 28, 39, and 67 with a solution 
containing  160 #l receptor peptide/hemocyanin,  340 ul of buffer A, and 500 ttl 
of either Freund's complete adjuvant (day 0) or incomplete adjuvant (days 14, 
28, 39, and 67). Rabbits were bled on days 35, 46, 74, and 88 by heart puncture. 
IgG fractions from immunized  and nonimmunized rabbits were prepared by 
affinity chromatography on Protein A-Sepharose (17). 
PAGE:  One-dimensional  electrophoresis  was carried  out on  6  or  8% 
polyacrylamide slab gels (14 x  8.5 x 0.15 cm) containing 0.1% (vol/vol) SDS 
(22). Samples were adjusted to a final concentration  of 0.2% SDS, 10% (vol/ 
vol) glycerol, 0.1% bromphenol blue, and  100 mM dithiothreitol. The samples 
were not heated. 
Immunoblotting:  Proteins  were transferred  from SDS  slab gels to 
nitrocellulose paper as described  (18) or spotted  directly onto nitrocellulose 
paper.  Lanes containing  sample proteins  were incubated  for 30 min at  37"C 
with 10-50 ml buffer B (50 mM Tris-chloride, 2 mM CaCl~, 85 mM NaCl at 
pH 8) containing  5% (wt/vol) BSA and 0.2% (vol/vol) Nonidet  P-40. Rabbit 
IgG fractions were added  at the  concentration  indicated  in the  legends, and 
incubations  were resumed for 2 h at room temperature.  The paper was rinsed 
twice with 10-50 ml buffer B containing 2% albumin, and incubated twice for 
20 min each in buffer B containing  2% albumin and 0.2% Nonidet P-40. The 
paper was incubated in buffer B containing  5% albumin,  0.2% Nonidet  P-40, 
and ~251-1abeled goat anti-rabbit IgG (18) at 5 x  106 cpm/ml (0.5 ~tg/ml) for 30 
min.  After being washed as described above and rinsed twice in buffer B, the 
paper was dried at 37"C for 45 min, and autoradiograms were obtained (l 8). 
Localization  of Anti-Receptor Peptide Binding Sites in Hu- 
man Fibroblasts by Indirect Immunofluorescence:  Skin  fibro- 
blasts from  a  healthy  subject and from a subject  with the  receptor-negative 
form of homozygous familial hypercholesterolemia were grown in monolayer 
culture and set up for experiments according to a standard format (17). On day 
7 of cell growth after incubation  for 48 h in lipoprotein-deficient  serum, cell 
monolayers grown on glass eoverslips were transferred to a fresh Pctri dish and 
then overlaid with 200 ul of ice-cold buffer C ( 10 mM sodium phosphate, 0.15 
M NaCI, and 2 mM MgC12 at pH 7.4) containing  either nonimmune lgG or 
anti-receptor peptide IgG at a final concentration  of 0.2 mg/ml. After incuba- 
tion  for  1 h at 4"C or 2 h at 37"C, the coverslips were washed extensively at 
4°C, fixed with  3%  paraformaldehyde,  and  rinsed with  5 mM  NH4C1 (17). 
Monolayers  that  had  been  incubated  with  IgG  at  37"C were  then  made 
permeable by incubation  for 5 min at -10*C with 3 ml of buffer C containing 
0.1%  (vol/vol)  Triton  X-100  (23). Coverslips  from  both  the  4*  and  37°C 
incubations were then placed cell-side up in a fresh Petri dish and covered with 
60 ~1 of goat anti-rabbit  IgG-fluorescein isothiocyanate (affinity purified) at a 
concentration  of 50 gg/ml. The coverslips were incubated  for  1 h at  37"C, 
washed at room temperature,  mounted on glass slides, and overlaid with 90% 
TABLE  I 
Amino Acid Sequence of the NH2-terminal Portion of the Bovine Adrenal LDL Receptor 
1  5  10  15 
Ala-VaI-Glu-Asp-Asn-Cys-Gly-Arg-Asn-Glu-Phe-Glu-Cys-GIn-(Asp)-Gly 
(  ), tentative assignment 
1636  R^P,D  CO~MUN,C^TIONS FIGURE  1  Immunoblot analysis of purified LDL receptor (left) and LDL receptor peptide (right)  with anti-receptor peptide IgG 
and anti-LDL receptor IgG. Purified  LDL receptor from bovine adrenal cortex or chemically synthesized  receptor peptide were 
applied to nitrocellulose paper as follows: The indicated amounts of LDL receptor or receptor peptide were dissolved in 10 p.I 
each of a solution of 5 mg/ml BSA in 0.15 M  NaCI and applied to dry nitrocellulose paper. The paper was dried at 4°C for 16 h 
and incubated with the indicated antibodies (5 #g/ml of nonimmune rabbit IgG, A and A'; 5/~g/ml of anti-receptor peptide IgG, 
B and B'; or 2.5 ~g/ml of anti-LDL receptor IgG, C and C'), followed by incubation with 1251-goat  anti-rabbit IgG and visualization 
by autoradiography. 
FIGURE 2  Immunoblot anal- 
ysis of  purified  LDL  recep- 
tor with anti-receptor pep- 
tide  IgG.  Purified  LDL  re- 
ceptor from  bovine adrenal 
cortex (2  #g/lane)  was sub- 
jected to electrophoresis on 
a  8%  SDS  polyacrylamide 
gel,  transferred  to  nitrocel- 
lulose paper, incubated with 
5  /~g/ml of  either  anti-re- 
ceptor peptide IgG or non- 
immune  IgG, followed  by 
incubation  with  1251-goat 
anti-rabbit IgG and visualiza- 
tion by autoradiography. Mr 
standards are indicated. 
the  anti-receptor  peptide  IgG  recognizes  the  intact  LDL 
receptor, the anti-receptor IgG does not recognize the receptor 
peptide. 
Further evidence that the anti-receptor peptide IgG reacted 
with the intact LDL receptor is provided by the data in Fig. 
2.  Purified  LDL receptor from bovine adrenal  cortex  was 
subjected to SDS PAGE, transferred to nitrocellulose paper, 
and incubated with the anti-receptor peptide IgG or control 
IgG from nonimmunized  rabbits.  The  nitrocellulose  paper 
glycerol  (23). The coverslips  were viewed  with  a Zeiss  photomicroscope  Ill, and 
photographs  were taken as described (  17, 23). 
RESULTS 
The LDL receptor from bovine adrenal cortex was purified 
to homogeneity (15),  and the first 16 amino acid residues at 
the NH2-terminal end of the  molecule were determined by 
automated sequencing methodology (Table I). A  16-amino 
acid  peptide  corresponding to  this  NH2-terminal  sequence 
(hereafter referred to as the "receptor peptide") was synthe- 
sized,  coupled to  keyhole limpet hemocyanin, and  used to 
immunize rabbits. IgG fractions from the antiserum of three 
rabbits were prepared,  and the  resulting lgG fractions were 
tested for their ability to bind to the purified LDL receptor, 
as  determined  by immunoblotting techniques.  Two of the 
three IgGs gave positive reactions. One of these was chosen 
for further study. 
When different amounts of the purified LDL receptor were 
spotted onto nitrocellulose paper and incubated with either 
the anti-receptor peptide IgG or an IgG fraction of a  poly- 
clonal  antiserum  directed  against  the  intact  receptor,  the 
receptor was stained by both antibodies (Fig.  1, left).  On the 
other  hand,  when  the  receptor  peptide  was  spotted  onto 
nitrocellulose, it was stained by the anti-receptor peptide IgG, 
but not by the anti-receptor IgG (Fig.  1, right).  Thus, whereas 
FIGURE 3  Immunoblot analysis of partially purified LDL receptor 
with anti-receptor peptide IgG. Partially purified LDL receptor from 
bovine adrenal cortex (DEAE-cellulose fraction)  (50 #g/lane)  was 
subjected to electrophoresis  on a 6% SDS polyacrylamide  gel. After 
electrophoresis,  one lane of the gel (,4) was stained with Coomassie 
Blue and photographed, and two lanes were transferred  to nitro- 
cellulose paper,  incubated with  5  #g/ml  of either anti-receptor 
peptide antibody (B) or nonimmune IgG (C), followed by incubation 
with 1251-goat  anti-rabbit IgG and visualization by autoradiography. 
Mr standards are indicated. 
RAP~O CoMMuN~c^TIONS  1637 FIGURE 4  Indirect immunofluorescence  staining pattern of LDL receptors in normal human fibroblasts (A and C) and homozygous 
familial hypercholesterolemia  fibroblasts  (B and D) after incubation with anti-receptor peptide IgG at 4°C (A and B) or 37°C (C 
and D). Monolayers of normal fibroblasts  or mutant fibroblasts were grown on glass coverslips and incubated with anti-receptor 
peptide IgG at either 4°C or 37°C. The coverslips were then washed, fixed in paraformaldehyde, permeabilized in the case  of C 
and D, and processed for indirect immunofluorescence localization of either surface-bound  (A and B) or internalized (C and D) 
binding sites for anti-receptor peptide IgG. A, x  800; B-D, x  750. 
1638  RAPID  COMMUNICATIONS was then incubated with an '25I-labeled goat anti-rabbit IgG. 
The anti-receptor peptide IgG from the  immunized rabbit 
reacted strongly with the I_,DL receptor; this gave an intense 
radioactive band at a position corresponding to a protein of 
160,000  mol wt. There was no reaction with the nonimmune 
IgG. 
Fig. 3 shows an experiment designed to test the specificity 
of the  anti-receptor peptide  IgG. A  crude  DEAE-cellulose 
fraction from an early step in the purification of the bovine 
adrenal LDL receptor (15) was subjected to SDS gel electro- 
phoresis and transferred to nitrocellulose paper. The receptor, 
which  represents  less  than  1%  of the  total  protein  in  this 
fraction (15),  is not visible by Coomassie Blue staining (Fig. 
3A).  However, when the nitrocellulose paper was incubated 
with the anti-receptor peptide IgG, the IgG bound specifically 
to  a  band  corresponding  in  molecular weight to  the  LDL 
receptor (Fig. 3 B). Nonimmune IgG did not stain (Fig. 3 C). 
We  next  sought  to  determine whether  the  anti-receptor 
peptide IgG would react with the LDL receptor on the surface 
of intact human fibroblasts. For this purpose, fibroblasts were 
incubated with the anti-receptor peptide IgG at 4°C and then 
fixed  and  stained  with  a  fluorescein-conjugated goat  anti- 
rabbit IgG. The anti-receptor peptide IgG was bound to the 
cell surface in a characteristic pattern consisting of punctate 
dots arranged in linear arrays (Fig. 4A). This distribution of 
fluorescence is identical to that which we have observed for 
LDL receptors stained with  polyclonal (24-26)  and mono- 
clonal antibodies ( 17, 26) directed against the intact receptor. 
No staining was observed when a nonimmune IgG was sub- 
stituted for the anti-receptor peptide IgG (data not shown). 
The specificity of the staining was further demonstrated by 
showing  that  fibroblasts  from  a  patient  with  homozygous 
familial  hypercholesterolemia,  which  lack  LDL  receptors, 
failed to bind the anti-receptor peptide IgG (Fig. 4B). 
Previous studies with polyclonal (24-26) and monoclonal 
(17,  26) antibodies directed against the intact LDL receptor 
have demonstrated that these antibodies are rapidly internal- 
ized by cells after they bind to the receptor at 37"C. A similar 
phenomenon  was  observed with  the  anti-receptor peptide 
IgG.  When  normal  fibroblasts  were  made  permeable  and 
incubated with the fluorescein-labeled goat anti-rabbit IgG, 
the anti-receptor peptide IgG was visualized as foci of fluo- 
rescence within the cell in a distribution that corresponds to 
endosomes  and  lysosomes (Fig.  4C).  No  immunoreactive 
staining was  seen  in  the  mutant  fibroblasts that  lack  LDL 
receptors (Fig. 4D). 
Despite its ability to bind to the LDL receptor of human 
fibroblasts and bovine adrenal cortex, the anti-receptor pep- 
tide IgG did not inhibit receptor binding of either 125I-LDL 
or of an  ~:5I-labeled monoclonal antibody (IgG-C7) directed 
against the receptor (17) (data not shown). 
DISCUSSION 
The intense current interest in endocytosis-mediating recep- 
tors has led to a widespread effort to elucidate the structural 
elements that enable these proteins to concentrate in coated 
pits. However, with the exception of the hepatic glycoprotein 
receptors  discussed  above,  little  is  known  of the  detailed 
structures  of this  class  of membrane  proteins  (5).  In  the 
current experiments we prepared a rabbit antiserum against a 
synthetic peptide corresponding to the 16 amino acids at the 
NH2-terminus of the bovine LDL receptor. The IgG fraction 
of this antiserum reacted with the intact bovine receptor as 
determined by immunoblotting techniques after electropho- 
resis of the receptor in  SDS polyacrylamide gels.  The anti- 
receptor peptide IgG also reacted with the human LDL recep- 
tor. When incubated with intact normal human fibroblasts, 
the anti-receptor peptide IgG bound to the receptor, where it 
could be visualized by indirect immunofluorescence. Specifc- 
ity of this reaction was confirmed by the failure of the anti- 
receptor peptide  IgG to bind to intact  fibroblasts that lack 
LDL receptors from a patient with the homozygous form of 
familial hypercholesterolemia. That the anti-receptor peptide 
IgG recognizes the intact LDL receptor from the human as 
well as the cow suggests a conserved amino acid sequence in 
this region of the molecule. 
The above results also suggest that the NH2-terminus of the 
LDL receptor is located on the external surface of the plasma 
membrane. Thus, the orientation of this receptor differs from 
that of the agalactoglycoprotein receptor of chicken liver (6) 
and the asialoglycoprotein receptor of rat liver (7),  both of 
whose NH2-termini face the cytoplasmic side  of the  mem- 
brane. Since both the LDL receptor and the hepatic glycopro- 
tein  receptors mediate rapid endocytosis of their respective 
ligands through coated pits (2, 27), the current findings indi- 
cate that the NH2-terminal/COOH-terminal orientation of a 
receptor molecule with respect to the plasma membrane is 
not a determinant of a receptor's interaction with coated pits. 
The current results also suggest that the extreme NH2-terminal 
region of the LDL receptor is not an essential component of 
the LDL binding domain since the anti-receptor peptide IgG 
does not block receptor binding of the lipoprotein. 
The groundwork for the current studies lies in the pioneer- 
ing work of Lerner and colleagues (see references 11 and  13) 
and of Doolittle and his associates (see reference 12). These 
investigators  showed  that  antibodies  against  certain  short 
synthetic peptides are capable of reacting with the correspond- 
ing amino acid sequences in large proteins. Apparently, short 
peptides may sometimes assume the same conformations that 
they  assume  in  large  proteins.  This  powerful  observation 
makes it possible to raise antibodies that react with specified 
regions  of proteins,  and  this  in  turn  makes  it  possible  to 
localize these regions with a high degree of accuracy. 
The orientation of  the COOH-terminus of  the LDL receptor 
is not yet known. If the receptor traverses the plasma mem- 
brane  only  once,  then  the  COOH-terminus must  face the 
cytoplasmic surface. However, it is possible that the receptor 
crosses the membrane several times; if so, the COOH-termi- 
nus might be on either side of the membrane. If the amino 
acid  sequence  of the  COOH-terminus  can  be  deduced,  it 
should  be  possible  to  localize  this  region  with  techniques 
similar to the ones employed in the current study. 
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